Home » Newsletters » BioWorld Science

BioWorld Science

May 18, 2020

View Archived Issues

Soluble VEGFR-1 is a diagnostic marker of bladder pain syndrome/interstitial cystitis

VSY Biotechnology developing TR-C 19 to treat COVID-19

Small-molecule amplifiers co-translationally increase CFTR mRNA stability through PCBP1 binding

Results from a multicenter phase IIa study of PF-06700841 in patients with plaque psoriasis

Identification of a novel series of 1,6-naphthyridinone-based class II MET kinase inhibitors

CureVac announces positive preclinical data for its coronavirus vaccine candidate

FDA approves Pomalyst for AIDS-related and HIV-negative Kaposi sarcoma

FDA clears IND for LB-1148 in COVID-19-associated pulmonary dysfunction

NantKwest and ImmunityBio to begin phase II study of combination immunotherapy

Phase IIb study of PTI-125 in Alzheimer's disease does not meet primary endpoint

Genenta presents phase I/II data for Temferon cell-based therapy in patients with GBM

First-in-human data for novel proliposomal paclitaxel, TSD-001, in NMIBC

Interim phase II data for apalutamide plus abiraterone acetate/prednisone in prostate cancer

Microbiome modulates effects of ALS mutation

Designer proteins for RSV vaccine

TNFAIP2 identified as potential therapeutic target in platinum-resistant urothelial carcinoma

Medshine Discovery discloses Wee1 inhibitors

Gilead Sciences divulges PD-1/PD-L1 interaction inhibitors

Intra-Cellular Therapies patents PDE2A inhibitors

FronThera US Pharmaceuticals synthesizes new TYK2 inhibitors

Novartis divulges NLRP3 inhibitors

Otoferlin gene therapy restores hearing in congenital deafness model

CCX-140 shows no meaningful reduction in proteinuria in phase II study in FSGS

Opdivo + Yervoy approved in U.S. for first-line metastatic NSCLC with PD-L1 expression >= 1%

FDA grants accelerated approval to Rubraca for BRCA-mutated metastatic CRPC

HPTN 083 interim analysis shows LA cabotegravir highly effective at preventing HIV

FDA approves Qinlock for fourth-line treatment of advanced GIST

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...